David Arkowitz - Chief Financial Officer at Seres Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
MCRB on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David Arkowitz since 4/22/2024

Holdings reported by David Arkowitz for Seres Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 182K $197K $1.08 Feb 16, 2024 Direct
Restricted Stock Units 31.9K $43K $1.35 Feb 15, 2024 Direct Common Stock
Stock Option (Right to Buy) 288K Feb 14, 2024 Direct Common Stock

Transactions reported by David Arkowitz for Seres Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.